NovoCure Ltd (NAS:NVCR)
$ 20.04 0.35 (1.78%) Market Cap: 2.17 Bil Enterprise Value: 1.88 Bil PE Ratio: 0 PB Ratio: 6.01 GF Score: 69/100

Novocure Ltd at Wells Fargo Virtual Healthcare Conference Transcript

Sep 09, 2020 / 12:40PM GMT
Release Date Price: $85.45 (+4.09%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

I'm Larry Biegelsen, the medical device analyst at Wells Fargo. I'm pleased to introduce the next company in our morning session on day 1 of our 2020 Virtual Health Care Conference, NovoCure. Joining us from the company are the Executive Chairman, Bill Doyle; and Chief Scientific Officer, Dr. Uri Weinberg. In terms of format, it will be a 30-minute fireside chat. So Bill and Uri, welcome, and thank you for joining us.

Uri Weinberg
NovoCure Limited - Chief Science Officer

Thanks for having us, Larry. It's our pleasure to be here.

Questions & Answers

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

Good. So we're going to try something a little different. We're going to try to do 1 audience polling question this morning. And we'll prompt the audience at the appropriate time. But Bill, let's quickly touch upon COVID before

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot